These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4700706)

  • 21. Amphetamine: differentiation by d and l isomers of behavior involving brain norepinephrine or dopamine.
    Taylor KM; Snyder SH
    Science; 1970 Jun; 168(3938):1487-9. PubMed ID: 5463064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-stimulation and catecholamines. 3. Effect of imposed or self-stimulation in the area ventralis tegmenti on catecholamine utilization in the rat brain.
    Stinus L; Thierry AM; Blanc G; Glowinski J; Cardo B
    Brain Res; 1973 Dec; 64():199-210. PubMed ID: 4781344
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychoactive drugs and neurotransmitters: differentiating dopamine and norepinephrine neuronal functions with drugs.
    Snyder SH; Taylor KM; Horn AS; Coyle JT
    Res Publ Assoc Res Nerv Ment Dis; 1972; 50():359-75. PubMed ID: 4341952
    [No Abstract]   [Full Text] [Related]  

  • 24. Aging and the passage of L-tyrosine, L-DOPA, and inulin into mouse brain slices in vitro.
    Finch CE; Jonec V; Hody G; Walker JP; Morton-Smith W; Alper A; Dougher GJ
    J Gerontol; 1975 Jan; 30(1):33-40. PubMed ID: 1109390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catecholamine concentration in discrete brain areas following the withdrawal of barbital dependent rats.
    Morgan WW; Pfeil KA; Gonzales EG
    Life Sci; 1977 Feb; 20(3):493-9. PubMed ID: 557159
    [No Abstract]   [Full Text] [Related]  

  • 26. Catecholamine biosynthesis in brains of rats treated with morphine.
    Clouet DH; Ratner M
    Science; 1970 May; 168(3933):854-6. PubMed ID: 5444061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DOPA decarboxylase in the developing rat brain.
    Lamprecht F; Coyle JT
    Brain Res; 1972 Jun; 41(2):503-6. PubMed ID: 4402608
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of chronically administered L-dopa in normal and lesioned cats.
    Langelier P; Roberge AG; Boucher R; Poirier LJ
    J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
    [No Abstract]   [Full Text] [Related]  

  • 29. Correlation between tyrosine hydroxylase activity and catecholamine concentration or turnover in brain regions.
    Bacopoulos NG; Bhatnagar RK
    J Neurochem; 1977 Oct; 29(4):639-43. PubMed ID: 22581
    [No Abstract]   [Full Text] [Related]  

  • 30. Cyclic AMP and cyclic GMP accumulation in vitro in brain regions of young, old and aged rats.
    Schmidt MJ; Thornberry JF
    Brain Res; 1978 Jan; 139(1):169-77. PubMed ID: 202373
    [No Abstract]   [Full Text] [Related]  

  • 31. Modification of striatal acetylcholine concentration by dopamine receptor agonists and antagonists.
    Sethy VH; VAN Woert MH
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):13-28. PubMed ID: 4847901
    [No Abstract]   [Full Text] [Related]  

  • 32. Changes in biogenic amine synthesis and turnover induced by hypoxia and/or foot shock stress. II. The central nervous system.
    Brown RM; Snider SR; Carlsson A
    J Neural Transm; 1974; 35(4):293-305. PubMed ID: 4548084
    [No Abstract]   [Full Text] [Related]  

  • 33. Thyroxine and brain catecholamines: increased transmitter synthesis and increased receptor sensitivity.
    Engström G; Svensson TH; Waldeck B
    Brain Res; 1974 Sep; 77(3):471-83. PubMed ID: 4855210
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in the formation of 3 H-catecholamines from 3 H-DOPA and 3 H-tyrosine induced by unlabelled DOPA.
    Persson T; Waldeck B
    Acta Pharmacol Toxicol (Copenh); 1971; 29(5):525-32. PubMed ID: 5171123
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the regional biosynthesis and metabolism of catecholamines in the central nervous system of the monkey.
    Goldstein M; Anagnoste B; Owen WS; Battista AF
    Experientia; 1967 Feb; 23(2):98-9. PubMed ID: 4382238
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes in brain catecholamine levels following DL-dopa are not potentiated by deuterium substitution.
    Dewar KM; Dyck LE; Durden DA; Boulton AA
    Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):675-80. PubMed ID: 3937178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Capability to produce conditioned reflexes and catecholamine metabolism in the brain].
    Krause M; Gwóźdź B; Steplewski Z; Pogorzelska T
    Acta Physiol Pol; 1970; 21(6):741-7. PubMed ID: 5491168
    [No Abstract]   [Full Text] [Related]  

  • 38. Alteration of rat brain catecholamine metabolism during exposure to hypobaric hypoxia.
    Cymerman A; Robinson SM; McCullough D
    Can J Physiol Pharmacol; 1972 Apr; 50(4):321-7. PubMed ID: 4402610
    [No Abstract]   [Full Text] [Related]  

  • 39. Monoamine metabolism during bicuculline-induced epileptic seizures in the rat.
    Calderini G; Carlsson A; Nordström CH
    Brain Res; 1978 Nov; 157(2):295-302. PubMed ID: 309780
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of L-3,5-[3H]-tyrosine and the measurement of tritiated water to estimate DA turnover in central dopaminergic terminals.
    Glowinski J
    Neuropharmacology; 1976 Oct; 15(10):585-90. PubMed ID: 11422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.